🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Allen C. Gao

University of California, Davis

ORCID: 0000-0002-5966-9038

Also affiliated with University of California, Berkeley

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models”.

Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models

Pharmacological Research(2023)10.1016/j.phrs.2023.106692
N/A
0.681DataRank · unranked
22 citations

Joy C. Yang, Shu Ning, Bo Chen, Christopher Nip, Qiang Wei +7 more

Resistance mechanisms to taxanes and PARP inhibitors in advanced prostate cancer

Current Opinion in Endocrine and Metabolic Research(2020)10.1016/j.coemr.2020.02.006
N/A
0DataRank · unranked
10 citations

Allen C. Gao, Alan P. Lombard

Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer

Scientific Reports(2021)10.1038/s41598-021-85969-x
N/A
0DataRank · unranked
85 citations

Chengfei Liu, Chun‐Yi Wu, Christopher P. Evans, Marc Dall’Era, Daniel Robles +5 more

Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer

Oncogene(2023)10.1038/s41388-022-02566-6
N/A
0DataRank · unranked
21 citations

Pengfei Xu, Shu Ning, Logan J. Wasielewski, Hans Adomat, Sung Hee Hwang +9 more

Data from Bidirectional Cross-talk between MAOA and AR Promotes Hormone-Dependent and Castration-Resistant Prostate Cancer

(2023)10.1158/0008-5472.c.6513082.v1
N/A
0DataRank · unranked
0 citations

Lijuan Yin, Jingjing Li, Jing Wang, Tianjie Pu, Peng Duan +4 more

Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer

Nature Communications(2024)10.1038/s41467-024-50459-x
N/A
0DataRank · unranked
10 citations

Joy C. Yang, Bo Chen, Shu Ning, Xiong Zhang, Leyi Wang +16 more

Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer

Oncogene(2024)10.1038/s41388-024-03081-6
N/A
0DataRank · unranked
5 citations

Pengfei Xu, Joy C. Yang, Christopher Nip, Leyi Wang, Yuqiu Shen +9 more

Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer

Research Square(2024)10.21203/rs.3.rs-4095949/v1
N/A
0DataRank · unranked
0 citations

Bo Chen, Pengfei Xu, Joy C. Yang, Christopher Nip, Leyi Wang +9 more

PlexinD1 is a driver and a therapeutic target in advanced prostate cancer

EMBO Molecular Medicine(2025)10.1038/s44321-024-00186-z
N/A
0DataRank · unranked
3 citations

J. Wang, Wen Guan, Jingjing Li, Tianjie Pu, Eva Corey +4 more

Inhibition of Galectin-1 and Androgen Receptor Axis Enhances Enzalutamide Treatment in Enzalutamide Resistant Prostate Cancer

Cancers(2025)10.3390/cancers17030351
N/A
0DataRank · unranked
3 citations

Allen C. Gao, Roger Xia, Chun‐Te Wu, Ssu-Wei Hsu, Ching‐Hsien Chen +2 more

Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate Cancer

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0015
N/A
0DataRank · unranked
82 citations

Shu Ning, Wei Lou, Joy C. Yang, Cameron M. Armstrong, Alan P. Lombard +5 more

Dynamic Reprogramming of Immune-Related Signaling During Progression to Enzalutamide Resistance in Prostate Cancer

Cancers(2025)10.3390/cancers17193187
N/A
0DataRank · unranked
2 citations

Huan Qu, Joy C. Yang, Wei Fan, Junwei Zhao, Menghuan Tang +9 more